The Amazon-Berkshire-JPM team makes a new appointment

By Catherine Sturman
Technology companies are increasingly entering the health space with enthusiasm and determination. The recent partnership of Amazon, Berkshire Hathaway...

Technology companies are increasingly entering the health space with enthusiasm and determination. The recent partnership of Amazon, Berkshire Hathaway and JPM is no exception.

Hiring a number of renowned healthcare experts in their chosen fields, Dana Gelb Safran, Senior Vice President of enterprise analytics at Blue Cross Blue Shield, has become the recent appointment which will further set the trio’s healthcare ambition alight.

Following on from the appointment of Atul Gawande in June, who has voiced his plans to incubate better models of care for all, the hiring of Safran will enable the trio to increasingly look at ways to lower healthcare costs and drive positive patient outcomes through the use of advanced data analytics.

See also

In her role as Chief Performance Measurement and Improvement Officer and Senior Vice President of Enterprise Analytics, Safran will become the first woman hired by the trio when she joins the venture early next year as Head of Measurement.

This year, Amazon has been making significant advances in healthcare. From its acquisition of online pharmacy start-up, PillPack to its partnership with blockchain innovator Ethereum, the tech giant has now begun to sell glucose monitors and blood pressure technologies direct to consumers, further accelerating its desire to disrupt the market

Share

Featured Articles

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19